Tag:#Gavin Sathianathan

News

‘Patient Capital’ Backing LSE Debutant As It Eyes A Multi-Billion Pound Prize

LONDON Stock Exchange debutant Oxford Cannabinoid Technologies is aiming to emulate the success of GW Pharmaceuticals. Its founders Gavin Sathianathan and Neil Mahapatra were two...

Peter - May 25, 2021

Markets

British Biotech Firm To List on the London Stock Exchange With A Valuation of Over £50m

BIOTECH company Oxford Cannabinoid Technologies to float on the London Stock Exchange in a listing which is set to value it at £51.5m It says...

Peter - May 18, 2021

News

Setback For Millions As Leading Global Pain Group Baulks At Medical Cannabis

DESPITE the United Nations recently recognising the medical benefits of cannabis, an influential global body says there is insufficient evidence to endorse it for...

Peter - March 22, 2021

Medicinal Cannabis

NHS Launching Patient Registry To Support Evidence Base For Cannabis Medicines

THE NHS is to launch is first-ever cannabis patient registry in a move which signifies an ambition for the medicines to become more widely-available...

Peter - December 14, 2020

Medicinal Cannabis

Huge Rise In UK Medical Cannabis Imports As Private Sector Steps-Up To Meet Patient Demand

NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s growing role in fulfilling...

Peter - December 1, 2020

News

New Patient Data App Can Help Clear The Hurdles To Medical Cannabis Scripts

SECURING patient-generated data and enabling them to speak the language of the health-care system is at the heart of a ground-breaking development by UK...

Peter - November 6, 2020

Latest news

Press ReleasesOctober 21, 2021

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...

- Advertisement -

NewsOctober 21, 2021

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

NewsOctober 20, 2021

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

Must read

NewsOctober 21, 2021

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

NewsOctober 20, 2021

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...

Tag:#Gavin Sathianathan

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Editor Picks

New Head At The Cannabis Trades Association Following The Loss Of Two Senior Directors

Amazon Enters CBD Retail Market – But Only In One Country

Huge Stride For UK Medicinal Cannabis With £12m Plan To Cultivate 300,000 Plants A Year

Must Read

Can CBD Be Sold As ‘Hemp Oil’ To Avoid Novel Food Rules?

Legal UK Cannabis Industry Mapped Out For First Time – And Poised For Rapid Change

Medical Properties Of Cannabis Recognised In Historic United Nations Vote

BusinessCann

About BusinessCann

Follow Us